Cargando…

Molecular characterization of proliferative lupus nephritis

Detalles Bibliográficos
Autores principales:	Parikh, Samir V, Song, Huijuan, Vance, Jay, Zing, Jianying, Yu, Lianbo, Malvar, Ana, Rovin, Brad H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179548/ http://dx.doi.org/10.1186/ar4648

Ejemplares similares

Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders
por: Parikh, Samir V, et al.
Publicado: (2015)

Rethinking Lupus Nephritis Classification on a Molecular Level
por: Almaani, Salem, et al.
Publicado: (2019)

Renal flare as a biomarker of incident and progressive chronic kidney disease in patients with lupus nephritis
por: Parikh, S, et al.
Publicado: (2012)

Cytokine profiles of lupus patients with or without nephritis
por: Rovin, BH, et al.
Publicado: (2012)

A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis
por: Parikh, Samir V., et al.
Publicado: (2021)

Differing environmental risk factors for membranous versus proliferative lupus nephritis
por: Dooley, MA, et al.
Publicado: (2012)

Contemporary estimates of the risk of end-stage renal disease in the first decade of proliferative lupus nephritis
por: Ward, MM, et al.
Publicado: (2012)

B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
por: Furie, Richard A, et al.
Publicado: (2022)

Time to lupus nephritis: impact of gender and ethnicity
por: Seligman, VA, et al.
Publicado: (2001)

Remission of lupus nephritis: the trajectory of histological response in successfully treated patients
por: Malvar, Ana, et al.
Publicado: (2023)

Expanding the Role of Complement Therapies: The Case for Lupus Nephritis
por: Li, Nicholas L., et al.
Publicado: (2021)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Methodological quality of studies of end-stage renal disease risks in lupus nephritis
por: Tektonidou, Maria, et al.
Publicado: (2014)

Sociodemographics and epidemiology of serious infections requiring hospitalization among adults with systemic lupus erythematosus and lupus nephritis, 2000 to 2006
por: Feldman, Candace H, et al.
Publicado: (2014)

In situ cognate interactions between T-follicular helper cells and B cells characterize severe tubulointerstitial inflammation in human lupus nephritis
por: Clark, MR, et al.
Publicado: (2012)

Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis
por: Clark, Marcus R, et al.
Publicado: (2014)

Patients with Proliferative Lupus Nephritis Have Autoantibodies That React to Moesin and Demonstrate Increased Glomerular Moesin Expression
por: Caster, Dawn J., et al.
Publicado: (2021)

Unmet medical needs in lupus nephritis: solutions through evidence-based, personalized medicine
por: Anders, Hans-Joachim, et al.
Publicado: (2015)

Rescue treatment of severe lupus myocarditis and proliferative lupus nephritis with immunoadsorption
por: Štambuk, Sandra Karanović, et al.
Publicado: (2023)

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy
por: Annavarajula, S. K., et al.
Publicado: (2011)

Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis
por: Gomez Mendez, Liliana Michelle, et al.
Publicado: (2019)

Usual source of care and geographic region are largest predictors of healthcare quality for incident lupus nephritis in US Medicaid recipients
por: Yazdany, J, et al.
Publicado: (2012)

Identification of stage-specific genes associated with lupus nephritis and response to remission induction in NZB/W and NZM2410 mice
por: Bethunaickan, Ramalingam, et al.
Publicado: (2014)

The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its Flare
por: Toy, Chris R., et al.
Publicado: (2021)

Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis
por: Romick-Rosendale, Lindsey E, et al.
Publicado: (2011)

Long-term renal outcomes of patients with non-proliferative lupus nephritis
por: Kang, Eun-Song, et al.
Publicado: (2023)

A Predictive Model for Estimation Risk of Proliferative Lupus Nephritis
por: Chen, Dong-Ni, et al.
Publicado: (2018)

Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis
por: Olson, S. W., et al.
Publicado: (2017)

Patient-Centered Outcomes Research Institute (PCORI) multisite project to develop treatment decision aids for racial/ethnic minorities with lupus nephritis
por: Yazdany, Jinoos, et al.
Publicado: (2014)

Low-Grade Proteinuria Does Not Exclude Significant Kidney Injury in Lupus Nephritis
por: De Rosa, Marcelo, et al.
Publicado: (2020)

Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial
por: Anders, Hans-Joachim, et al.
Publicado: (2023)

Expression and regulation of discoidin domain receptor 1 (DDR1) – a novel receptor for collagen – in normal human renal cells and patients with lupus nephritis
por: Boumpas, DT, et al.
Publicado: (2003)

Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis
por: Gonzalo, Elena, et al.
Publicado: (2012)

The Steroids In the Maintenance of remission of Proliferative Lupus nephritis (SIMPL) pilot trial
por: Galbraith, Lauren, et al.
Publicado: (2014)

Hydroxychloroquine in children with proliferative lupus nephritis: a randomized clinical trial
por: Gheet, Fatma Sayed, et al.
Publicado: (2023)

Variation in renal biopsy and medication prescribing practices among pediatric Medicaid patients with lupus nephritis prior to end-stage renal disease in the US, 2000 to 2004
por: Hiraki, LT, et al.
Publicado: (2012)

Limited Reliability of the Spot Urine Protein/Creatinine Ratio in the Longitudinal Evaluation of Patients With Lupus Nephritis
por: Shidham, Ganesh, et al.
Publicado: (2018)

Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints
por: Almaani, Salem, et al.
Publicado: (2020)

Developing consensus treatment plans for proliferative lupus nephritis in childhood-onset systemic lupus erythematous
por: Mina, Rina, et al.
Publicado: (2012)

Daratumumab in Patients With Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits
por: Almaani, Salem, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lblrlvvn048kiltshv8lbrqrm0